TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 29.835
EU - Europa 22.437
AS - Asia 14.326
SA - Sud America 3.048
AF - Africa 318
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 57
AN - Antartide 1
Totale 70.150
Nazione #
US - Stati Uniti d'America 28.552
SG - Singapore 5.556
RU - Federazione Russa 5.354
GB - Regno Unito 4.533
IT - Italia 4.476
CN - Cina 3.698
BR - Brasile 2.543
DE - Germania 2.296
UA - Ucraina 1.973
VN - Vietnam 1.847
DK - Danimarca 1.239
KR - Corea 1.066
CA - Canada 1.039
HK - Hong Kong 778
SE - Svezia 463
FR - Francia 382
FI - Finlandia 358
IE - Irlanda 330
IN - India 311
PL - Polonia 270
AR - Argentina 200
NL - Olanda 195
MX - Messico 160
ES - Italia 144
ZA - Sudafrica 137
BD - Bangladesh 133
EU - Europa 126
TR - Turchia 124
ID - Indonesia 122
JP - Giappone 122
EC - Ecuador 100
IL - Israele 92
IQ - Iraq 84
AT - Austria 82
BE - Belgio 59
AU - Australia 51
LT - Lituania 49
CH - Svizzera 47
CO - Colombia 44
PK - Pakistan 44
MA - Marocco 39
PH - Filippine 38
UZ - Uzbekistan 37
PE - Perù 36
VE - Venezuela 36
PT - Portogallo 34
PY - Paraguay 34
MY - Malesia 33
CL - Cile 29
TW - Taiwan 28
AE - Emirati Arabi Uniti 26
JO - Giordania 26
SA - Arabia Saudita 26
IR - Iran 25
RO - Romania 22
KE - Kenya 21
EG - Egitto 20
JM - Giamaica 18
TH - Thailandia 16
BG - Bulgaria 15
DO - Repubblica Dominicana 15
NP - Nepal 15
UY - Uruguay 14
GR - Grecia 13
KZ - Kazakistan 13
TN - Tunisia 13
AZ - Azerbaigian 12
RS - Serbia 12
ML - Mali 11
NG - Nigeria 11
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
ET - Etiopia 10
SN - Senegal 10
AL - Albania 9
BA - Bosnia-Erzegovina 9
SK - Slovacchia (Repubblica Slovacca) 9
CY - Cipro 8
HN - Honduras 8
LV - Lettonia 8
OM - Oman 8
PA - Panama 8
SI - Slovenia 8
GH - Ghana 7
HR - Croazia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
BY - Bielorussia 6
HU - Ungheria 6
AM - Armenia 5
GY - Guiana 5
LU - Lussemburgo 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AO - Angola 4
BH - Bahrain 4
CR - Costa Rica 4
GD - Grenada 4
Totale 70.079
Città #
Dallas 6.140
Singapore 3.128
Southend 3.055
Chandler 2.063
Beijing 1.902
Woodbridge 1.736
Houston 1.562
Ashburn 1.522
Ann Arbor 1.350
San Mateo 1.164
Moscow 956
Jacksonville 945
Dearborn 840
Daejeon 815
Fairfield 780
Hong Kong 756
Falls Church 629
Cambridge 603
Wilmington 571
Pisa 547
Los Angeles 469
Seattle 442
Ho Chi Minh City 434
Hefei 408
Dong Ket 397
Stevenage 379
Boardman 367
Portsmouth 357
Montréal 339
The Dalles 331
Lawrence 325
Milan 316
Dublin 304
Rome 281
São Paulo 277
New York 276
Munich 264
Hanoi 249
Seoul 245
Warsaw 238
Beauharnois 228
Brooklyn 219
Santa Clara 203
Fremont 191
Buffalo 189
Ottawa 171
Redwood City 147
Old Bridge 129
Salerno 128
London 118
Denver 113
Montreal 109
Stockholm 103
Chicago 102
San Diego 99
Council Bluffs 97
Johannesburg 96
Florence 94
Tokyo 93
Mcallen 91
Poplar 91
Atlanta 88
Chennai 88
Rio de Janeiro 75
Tel Aviv 74
Phoenix 73
Orem 70
Toronto 69
Mexico City 65
Nuremberg 65
Bologna 62
Boston 60
Ankara 59
Norwalk 59
Guangzhou 58
Helsinki 57
Wuxi 56
San Francisco 54
Manchester 53
Da Nang 51
Serra 51
Belo Horizonte 49
Brasília 48
Turin 46
Haiphong 41
Mumbai 39
Frankfurt am Main 38
Biên Hòa 37
Guayaquil 37
Vienna 37
Porto Alegre 36
Duncan 34
Paris 34
Tashkent 34
Torino 34
Amsterdam 33
Shanghai 33
Redmond 32
Curitiba 31
Foggia 31
Totale 42.564
Nome #
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 828
Nutri-Score and Food Perception: Insights from an Italian Study 706
On Robots and Insurance 531
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 475
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 469
A new organizational integrated home-care model: An Italian pilot study 458
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 425
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 404
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 392
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 378
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 357
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 336
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 333
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 332
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 331
The Effect of using Serifs in Brand Names on Luxury Perception 330
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 321
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 316
Marketing per la Sanità. Logiche e strumenti 300
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 300
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 298
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 295
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 289
Early assessment of neuro-rehabilitation technology: a case study 288
Health technology assessment. Evaluation of biomedical innovative technologies 288
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 285
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 285
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 285
A Pitcure of Private Health Insurance Policyholders in Italy 285
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 283
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 278
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 278
Early assessment of neuro-rehabilitation technology 277
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 277
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 271
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 268
Cost analysis of the robotic surgery in Italy 267
A systematic literature review of the economic impact of ankylosing spondylitis 264
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 263
An economic evaluation of different procedures in bariatric surgery 263
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 262
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 261
Early assessment of neuro – rehabilitation technology: a case study 258
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 256
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 254
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 253
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 251
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 251
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 249
Is EEG Suitable for Marketing Research? A Systematic Review 249
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 248
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 248
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 247
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 247
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 246
Topic modeling and user network analysis on twitter during world lupus awareness day 246
Natural and man-made disasters: challenges and international perspectives for insurance 245
A registry for the collection of data in cochlear implant patients 243
Innovation in rehabilitation technology 242
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 237
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 236
Assessing the value of the use of diagnostic technology: trade offs for GPs 236
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 236
How colour saturation accelerates purchase behaviour, and influences food choice: 234
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 234
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 234
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 233
The quality of life of patients treated with robotic versus traditional surgery: results from an Italian observational multicenter study 231
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 231
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 231
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 230
L’Economia digitale e il settore assicurativo 229
Dentro, attraverso, oltre la crisi: il caso El.En 228
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 228
Economic impact of drug addiction interventions in adult population: The Peru case 228
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 227
Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura 225
Technology and innovative services. Toward a megamarket response to aging 225
Telerehabilitation after total knee replacement in Italy: cost-effectiveness and cost-utility analysis of a mixed telerehabilitation-standard rehabilitation programme compared with usual care 225
Evidence-gathering across industry and academia on early Health Technology Assessment (HTA) of medical devices: survey design and piloting 224
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 223
PADLOck: Thefts of medicines and Hospital Pharmacies' safety. An Italian study 223
Economic Impact of Employment Status on The Social Cost of Morbid Obese Patients Submitted to Bariatric Surgery 222
The Impact of Robotic Technology on Neuro-Rehabilitation: Preliminary Results on Acceptability And Effectiveness 222
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 222
Il PDTA del paziente con adenocarcinoma gastrico: analisi organizzativa di cinque centri del Veneto 222
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 222
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 220
The organizational analysis of ‘patient diagnostic therapeutic pathway’ for patients with gastric cancer in five centres of the Veneto Region (Italy) 220
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 220
Cochlear implant in prelingual deafened oralist adults: Speech perception outcome, subjective benefits and quality of life improvement 219
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 218
Telerehabilitation after Total Knee Replacement: Preliminary Cost-Utility Analysis of an Innovative Device 218
Il Governo della Sanità 217
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 217
Anatomic and functional imaging to predict long-term outcome and benefits of early revascularization in patients with suspected coronary artery disease: results from the EVINCI study 217
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 217
The social cost of chronic kidney disease in Italy 216
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 216
La Pubblicità in Sanità: Opportunità e Minacce di uno Strumento Potente 215
Totale 27.893
Categoria #
all - tutte 367.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 367.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.392 0 0 0 0 0 844 549 445 528 341 697 988
2021/20224.643 151 871 157 297 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202621.532 1.956 5.594 4.216 4.334 4.131 1.301 0 0 0 0 0 0
Totale 70.571